Raptor Pharmaceuticals Corp. is a publicly traded company quoted on the Over-the-Counter Bulletin Board under the symbol RPTP.OB.

Raptor Pharmaceuticals Corp.’s business consists of two segments: its 100% ownership of Raptor Pharmaceutical Inc., a development stage biotechnology company which bioengineers novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein and related proteins; and its 100% ownership of Bennu Pharmaceuticals Inc., a development stage company formed to develop clinical-stage products to marketing approval and commercialization.